TRASTUZUMAB DERUXTECAN
Clinical trials for TRASTUZUMAB DERUXTECAN explained in plain language.
Never miss a new study
Get alerted when new TRASTUZUMAB DERUXTECAN trials appear
Sign up with your email to follow new studies for TRASTUZUMAB DERUXTECAN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Real-World data sought on breast cancer drug in russia
Knowledge-focused Recruiting nowThis study will collect and analyze real-world medical records from 60 Russian adults with advanced HER2-positive breast cancer who have already received at least one cycle of trastuzumab deruxtecan. The goal is to see how well the drug works in everyday practice, including how l…
Matched conditions: TRASTUZUMAB DERUXTECAN
Phase: NA • Sponsor: Blokhin's Russian Cancer Research Center • Aim: Knowledge-focused
Last updated May 26, 2026 08:20 UTC
-
Can switching breast cancer drugs improve outcomes? new study investigates
Knowledge-focused Recruiting nowThis study observes 100 people in Korea with advanced HER2-positive breast cancer who will receive the drug T-DM1 immediately after stopping T-DXd. The goal is to see how long the cancer stays under control with this treatment sequence. Researchers will track tumor scans and surv…
Matched conditions: TRASTUZUMAB DERUXTECAN
Sponsor: Seoul National University Hospital • Aim: Knowledge-focused
Last updated May 22, 2026 13:50 UTC